178 related articles for article (PubMed ID: 12663161)
1. In vitro evaluation of combination of terbinafine with itraconazole or amphotericin B against Zygomycota.
Gómez-López A; Cuenca-Estrella M; Mellado E; Rodríguez-Tudela JL
Diagn Microbiol Infect Dis; 2003 Mar; 45(3):199-202. PubMed ID: 12663161
[TBL] [Abstract][Full Text] [Related]
2. In vitro evaluation of the type of interaction obtained by the combination of terbinafine and itraconazole, voriconazole, or amphotericin B against dematiaceous molds.
Biancalana FS; Lyra L; Schreiber AZ
Antimicrob Agents Chemother; 2011 Sep; 55(9):4485-7. PubMed ID: 21690288
[TBL] [Abstract][Full Text] [Related]
3. In vitro interaction of terbinafine with itraconazole and amphotericin B against fungi causing chromoblastomycosis in China.
Yu J; Li R; Zhang M; Liu L; Wan Z
Med Mycol; 2008 Nov; 46(7):745-7. PubMed ID: 18608889
[TBL] [Abstract][Full Text] [Related]
4. In vitro interaction of terbinafine with itraconazole, fluconazole, amphotericin B and 5-flucytosine against Aspergillus spp.
Mosquera J; Sharp A; Moore CB; Warn PA; Denning DW
J Antimicrob Chemother; 2002 Aug; 50(2):189-94. PubMed ID: 12161398
[TBL] [Abstract][Full Text] [Related]
5. Synergistic interaction of terbinafine with triazoles or amphotericin B against Aspergillus species.
Ryder NS; Leitner I
Med Mycol; 2001 Feb; 39(1):91-5. PubMed ID: 11270414
[TBL] [Abstract][Full Text] [Related]
6. In-vitro activities of terbinafine, itraconazole and amphotericin B against Aspergillus and Cladosporium species.
Kantarcioğlu AS; Yucel A
J Chemother; 2002 Dec; 14(6):562-7. PubMed ID: 12583546
[TBL] [Abstract][Full Text] [Related]
7. In vitro activity of amphotericin B, itraconazole, terbinafine and 5-fluocytosine against Exophiala spinifera and evaluation of post-antifungal effects.
Vitale RG; De Hoog GS; Verweij PE
Med Mycol; 2003 Aug; 41(4):301-7. PubMed ID: 12964723
[TBL] [Abstract][Full Text] [Related]
8. In vitro susceptibility testing of ciclopirox, terbinafine, ketoconazole and itraconazole against dermatophytes and nondermatophytes, and in vitro evaluation of combination antifungal activity.
Gupta AK; Kohli Y
Br J Dermatol; 2003 Aug; 149(2):296-305. PubMed ID: 12932235
[TBL] [Abstract][Full Text] [Related]
9. In vitro interaction of itraconazole with amphotericin B, caspofungin, and terbinafine against clinical isolates of Trichosporon asahii.
Li H; Qiao J; Wan Z; Zhang J
Mycopathologia; 2011 May; 171(5):345-8. PubMed ID: 21153882
[TBL] [Abstract][Full Text] [Related]
10. In-vitro interaction of terbinafine with amphotericin B, fluconazole and itraconazole against clinical isolates of Candida albicans.
Barchiesi F; Di Francesco LF; Compagnucci P; Arzeni D; Giacometti A; Scalise G
J Antimicrob Chemother; 1998 Jan; 41(1):59-65. PubMed ID: 9511038
[TBL] [Abstract][Full Text] [Related]
11. In vitro evaluation of combination antifungal activity against Fusarium species isolated from ocular tissues of keratomycosis patients.
Li L; Wang Z; Li R; Luo S; Sun X
Am J Ophthalmol; 2008 Nov; 146(5):724-8. PubMed ID: 18707669
[TBL] [Abstract][Full Text] [Related]
12. In vitro interactions between antifungals and methotrexate against Aspergillus spp.
Yang J; Wan Z; Wang X; Liu W; Li R
Mycopathologia; 2009 Nov; 168(5):237-42. PubMed ID: 19548112
[TBL] [Abstract][Full Text] [Related]
13. In vitro activities of terbinafine against Aspergillus species in comparison with those of itraconazole and amphotericin B.
Moore CB; Walls CM; Denning DW
Antimicrob Agents Chemother; 2001 Jun; 45(6):1882-5. PubMed ID: 11353643
[TBL] [Abstract][Full Text] [Related]
14. In vitro susceptibility of clinical isolates of Zygomycota to amphotericin B, flucytosine, itraconazole and voriconazole.
Gómez-López A; Cuenca-Estrella M; Monzón A; Rodriguez-Tudela JL
J Antimicrob Chemother; 2001 Dec; 48(6):919-21. PubMed ID: 11733480
[TBL] [Abstract][Full Text] [Related]
15. Susceptibility of clinical isolates of Fusarium to antifungal drugs.
Speeleveld E; Gordts B; Van Landuyt HW; De Vroey C; Raes-Wuytack C
Mycoses; 1996; 39(1-2):37-40. PubMed ID: 8786755
[TBL] [Abstract][Full Text] [Related]
16. In vitro interactions of licensed and novel antifungal drugs against Fusarium spp.
Ortoneda M; Capilla J; Javier Pastor F; Pujol I; Guarro J
Diagn Microbiol Infect Dis; 2004 Jan; 48(1):69-71. PubMed ID: 14761725
[TBL] [Abstract][Full Text] [Related]
17. In vitro activities of posaconazole, ravuconazole, terbinafine, itraconazole and fluconazole against dermatophyte, yeast and non-dermatophyte species.
Gupta AK; Kohli Y; Batra R
Med Mycol; 2005 Mar; 43(2):179-85. PubMed ID: 15832561
[TBL] [Abstract][Full Text] [Related]
18. In vitro activity of terbinafine against medically important non-dermatophyte species of filamentous fungi.
Garcia-Effron G; Gomez-Lopez A; Mellado E; Monzon A; Rodriguez-Tudela JL; Cuenca-Estrella M
J Antimicrob Chemother; 2004 Jun; 53(6):1086-9. PubMed ID: 15102749
[TBL] [Abstract][Full Text] [Related]
19. In vitro activities of terbinafine in combination with fluconazole and itraconazole against isolates of Candida albicans with reduced susceptibility to azoles.
Barchiesi F; Falconi Di Francesco L; Scalise G
Antimicrob Agents Chemother; 1997 Aug; 41(8):1812-4. PubMed ID: 9257768
[TBL] [Abstract][Full Text] [Related]
20. Drug combinations against Mucor irregularis in vitro.
Zhang S; Li R; Yu J
Antimicrob Agents Chemother; 2013 Jul; 57(7):3395-7. PubMed ID: 23587956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
